These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12966370)

  • 1. Busulfan induces activin A expression in vitro and in vivo: a possible link to venous occlusive disease.
    Dressel D; Ritter CA; Sperker B; Grube M; Maier T; Klingebiel T; Siegmund W; Beck JF; Kroemer HK
    Clin Pharmacol Ther; 2003 Sep; 74(3):264-74. PubMed ID: 12966370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential anti-inflammatory role of activin A in acute coronary syndromes.
    Smith C; Yndestad A; Halvorsen B; Ueland T; Waehre T; Otterdal K; Scholz H; Endresen K; Gullestad L; Frøland SS; Damås JK; Aukrust P
    J Am Coll Cardiol; 2004 Jul; 44(2):369-75. PubMed ID: 15261933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis.
    Gaedeke J; Boehler T; Budde K; Neumayer HH; Peters H
    Nephrol Dial Transplant; 2005 Feb; 20(2):319-28. PubMed ID: 15673690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis.
    Reimer J; Bien S; Ameling S; Hammer E; Völker U; Hempel G; Boos J; Kroemer HK; Ritter CA
    Eur J Clin Pharmacol; 2012 Jun; 68(6):923-35. PubMed ID: 22286157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation.
    Copelan EA; Bechtel TP; Avalos BR; Elder PJ; Ezzone SA; Scholl MD; Penza SL
    Bone Marrow Transplant; 2001 Jun; 27(11):1121-4. PubMed ID: 11551021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activin A induces cell proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.
    Ota F; Maeshima A; Yamashita S; Ikeuchi H; Kaneko Y; Kuroiwa T; Hiromura K; Ueki K; Kojima I; Nojima Y
    Arthritis Rheum; 2003 Sep; 48(9):2442-9. PubMed ID: 13130463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: intravenous versus oral busulfan--perhaps not as different as suggested.
    Slattery JT
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):282-4. PubMed ID: 12720221
    [No Abstract]   [Full Text] [Related]  

  • 8. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma.
    Karagiannidis C; Hense G; Martin C; Epstein M; Rückert B; Mantel PY; Menz G; Uhlig S; Blaser K; Schmidt-Weber CB
    J Allergy Clin Immunol; 2006 Jan; 117(1):111-8. PubMed ID: 16387593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa).
    Bouligand J; Boland I; Valteau-Couanet D; Deroussent A; Kalifa C; Hartmann O; Vassal G
    Bone Marrow Transplant; 2003 Nov; 32(10):979-86. PubMed ID: 14595385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells.
    Chattopadhyay N; T-Felt Hansen J; Godbole MM; Brown EM
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):146-50. PubMed ID: 14969747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics and early clinical outcomes.
    Zwaveling J; den Hartigh J; Lankester AC; Guchelaar HJ; Egeler RM; Bredius RG
    Anticancer Drugs; 2006 Oct; 17(9):1099-105. PubMed ID: 17001185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of the expression of activin A in esophageal carcinoma.
    Yoshinaga K; Mimori K; Yamashita K; Utsunomiya T; Inoue H; Mori M
    Int J Oncol; 2003 Jan; 22(1):75-80. PubMed ID: 12469187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation.
    Tran H; Petropoulos D; Worth L; Mullen CA; Madden T; Andersson B; Choroszy M; Nguyen J; Webb SK; Chan KW
    Biol Blood Marrow Transplant; 2004 Nov; 10(11):805-12. PubMed ID: 15505611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients.
    Zwaveling J; Press RR; Bredius RG; van Derstraaten TR; den Hartigh J; Bartelink IH; Boelens JJ; Guchelaar HJ
    Ther Drug Monit; 2008 Aug; 30(4):504-10. PubMed ID: 18641537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin and follistatin in rat mammary gland.
    Bussmann UA; Lanuza GM; Bussmann LE
    Mol Cell Endocrinol; 2004 Jun; 221(1-2):9-19. PubMed ID: 15223128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.
    Huang HM; Chiou HY; Chang JL
    J Cell Biochem; 2006 Jul; 98(4):789-97. PubMed ID: 16440334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal regulation of activin A and inhibin B by interleukin-1 (IL-1) and follicle-stimulating hormone (FSH) in rat Sertoli cells in vitro.
    Okuma Y; Saito K; O'Connor AE; Phillips DJ; de Kretser DM; Hedger MP
    J Endocrinol; 2005 Apr; 185(1):99-110. PubMed ID: 15817831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies.
    Williams CB; Day SD; Reed MD; Copelan EA; Bechtel T; Leather HL; Wingard JR; Abbott BL; Abhyankar S; McGuirk JP
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):614-23. PubMed ID: 15319773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the relationship between activin A, follistatin and preeclampsia].
    Zhao L; Shang T; Wang YL; Tang S; Li H; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):676-9. PubMed ID: 14728855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation.
    Schechter T; Finkelstein Y; Doyle J; Verjee Z; Moretti M; Koren G; Dupuis LL
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):307-14. PubMed ID: 17317584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.